Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 5 Results from Cox regression model evaluating the association between Methylation-based Resilience Score (MRS) and disease progression (CN to MCI/AD, MCI to AD) in 538 subjects, adjusted for age, sex, APOE ε4 status, baseline diagnosis, MMSE, and education. Significant association was observed for MRS (estimate = − 0.035, P-value = 0.00406), indicating higher MRS reduces risk of progression in AD

From: DNA methylation signature of a lifestyle-based resilience index for cognitive health